Page last updated: 2024-08-17

egtazic acid and Stroke

egtazic acid has been researched along with Stroke in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bornstein, N; Diener, HC; Gorelick, PB; Lees, K; Rosenberg, G; Shuaib, A1
Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA1
Bornstein, N; Diener, HC; Gorelick, PB; Lees, KR; Rosenberg, G; Shuaib, A1

Reviews

1 review(s) available for egtazic acid and Stroke

ArticleYear
Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:5

    Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical

2012

Trials

2 trial(s) available for egtazic acid and Stroke

ArticleYear
The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
    International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Double-Blind Method; Egtazic Acid; Female; Humans; Male; Middle Aged; Research Design; Stroke; Young Adult

2011
Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
    Stroke, 2013, Volume: 44, Issue:3

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Egtazic Acid; Endpoint Determination; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome

2013